Sponsoring Agency HHS
    POP 8/31/13 - 8/30/20 (6 years)


The NCI is one of the world's largest public sponsors of clinical trials in cancer, supporting a broad range of prevention, diagnostic, imaging, and treatment studies of new drugs, procedures and multi-modality approaches for oncology patients. Developmental work for new treatments has traditionally been carried out in a limited number of institutions while definitive studies comparing new treatments to the standard of care have required multi-center collaborations. The NCI, through its Cancer Therapy Evaluation Program (CTEP), Division of Cancer Treatment and Diagnosis (DCTD) and other Divisions/Programs supports multiple sites and investigators in North America to collaborate in multi-center trials/studies. These NCI multi-center programs each maintain the necessary infrastructure needed to successfully perform clinical trials/studies.The CTSU provides a wide-variety of operational, administrative, regulatory, and logistical support services to NCI multi-center coordinating centers and participating sites.

  • $71.4m Aggregate Dollars Obligated
  • $71.4m Aggregate Base & Exercised Options
  • $71.4m Aggregate Base & All Options (Ceiling)

Market Stats Related Contracts